Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
07/10/2003 | US20030130525 Method of preparing 3-methylindole derivatives through hydrogenation |
07/10/2003 | US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s) |
07/10/2003 | US20030130509 Process to produce 3-carbon amino alcohol salts |
07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
07/10/2003 | US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
07/10/2003 | US20030130337 Indole derivatives as anti-inflammatory agents |
07/10/2003 | US20030130335 Protein tyrosine phosphatases inhibitors |
07/10/2003 | US20030130307 Heterocycles |
07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
07/10/2003 | US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents |
07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
07/10/2003 | US20030130234 Novel indolinones and uses thereof |
07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
07/10/2003 | US20030129591 Linker arms for nanocrystals and compounds thereof |
07/10/2003 | US20030129590 Linker arms for nanocrystals and compounds thereof |
07/10/2003 | CA2482392A1 Carboxylic acid derivative |
07/10/2003 | CA2471236A1 Urea derivatives |
07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
07/09/2003 | EP1325911A1 Method for preparing 3-methylindole derivatives through hydrogenation |
07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
07/09/2003 | EP1324974A2 Drugs for diabetes |
07/09/2003 | EP1165496B1 Substituted aniline compounds |
07/09/2003 | EP1040096B1 Neuroprotective agents |
07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
07/09/2003 | CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
07/09/2003 | CN1113890C Heterocyclic metallocenes and polymerization catalysts |
07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
07/08/2003 | US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) |
07/08/2003 | US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes. |
07/08/2003 | US6589975 Synthetic compounds for treatment of inflammation |
07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
07/08/2003 | US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production |
07/08/2003 | US6589452 Polyerized crystalline colloid array |
07/08/2003 | CA2278845C Process for preparing quinolone and naphthyridone carboxylic acids |
07/03/2003 | WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists |
07/03/2003 | WO2003053927A1 Piperazine derivative |
07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
07/03/2003 | WO2003053922A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
07/03/2003 | WO2003053885A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
07/03/2003 | US20030125569 Use of packing strip as a holographic data carrier |
07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
07/03/2003 | US20030125371 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
07/03/2003 | US20030125369 New indenoindolone compounds |
07/03/2003 | US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline |
07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
07/03/2003 | US20030125320 Seratonin reuptake inhibitors potently binding to the 5-HT1A receptor, dopaminergic agents; antidepressants, psychosis, anxiolytic and antiischemic agents; panic order; obsessive compulsive disorder, impulse control disorder, alcohol abuse |
07/03/2003 | US20030124059 Imaging agents, precursors thereof and methods of manufacture |
07/03/2003 | US20030124028 Drug screening; library models |
07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
07/03/2003 | CA2470808A1 Piperazine derivative |
07/03/2003 | CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
07/03/2003 | CA2470141A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
07/02/2003 | EP1323729A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof derivatives; and use in the synthesis of perindopril |
07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
07/02/2003 | EP1322710A1 Modified carbocyanine dyes and their conjugates |
07/02/2003 | EP1322630A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
07/02/2003 | EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
07/02/2003 | EP1322160A1 Active ingredient combinations comprising insecticidal and acaricidal properties |
07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |
07/02/2003 | CN1427829A Substituted phenylacetamides and their use as glucokinase activators |
07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
07/02/2003 | CN1427824A Indole derivatives, process for preparation of same and use thereof |
07/02/2003 | CN1427718A Pharmaceutical compounds for treating COPD |
07/01/2003 | US6587251 Electrochromic solution containing hydrazone compound and device manufactured with same |
07/01/2003 | US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates |
07/01/2003 | US6586618 Amination 1,3-dihydoxynaphthalene, then blocking, iodination, alkylation, cyclization and deblocking to give (5-hydroxy-3-amino-1-(S)-(chloromethyl)-1,2-dihydro-3H-benz(e)indole), used as chemical intermediates of antitumor agents |
07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
07/01/2003 | US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
07/01/2003 | US6586459 Antithrombotic agents |
07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
07/01/2003 | US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders |
07/01/2003 | US6586368 Condensed heterocylic compounds and herbicides containing them |
06/26/2003 | WO2003051900A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
06/26/2003 | WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof |
06/26/2003 | WO2003051865A1 Dioxathianones |
06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051838A2 Protein kinase inhibitors |
06/26/2003 | WO2003051837A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
06/26/2003 | WO2003051291A2 Substituted 5-hydroxy-indole compounds for the treatment of glaucoma |
06/26/2003 | WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
06/26/2003 | WO2002060340A3 Method for identifying maxi-k channel blockers |
06/26/2003 | US20030120084 Forming 8-aminooctanoic acid hydrochloride by reacting halogenated carboxylic acid ester with metal cyanate and alcohol, then saponifying |
06/26/2003 | US20030120073 Such as d-4-hydroxyphenylglycine methyl ester for treatment of autoimmune diseases, glucose intolerance, diabetes, obesity, cancer, and psoriasis; drug screening |
06/26/2003 | US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents |
06/26/2003 | US20030119902 Novel aminobenzoephenones |